Targeting Brain Inflammation to Treat Methamphetamine Addiction #UCLAMDChat – Keith Heinzerling, MD
PublishedApril 28, 2014
Targeting Brain Inflammation to Treat Methamphetamine Addiction #UCLAMDChat – Keith Heinzerling, MD — UCLA addiction and internal medicine physician Keith Heinzerling, MD., medical director of the UCLA Center for Behavioral and Addiction Medicine, discusses n…
Do the Math: Ram Selvaraju on the Appeal of Biotechs in Orphan Diseases
To cast a spotlight on disruptive biotechnology stocks, Raghuram "Ram" Selvaraju of Aegis Capital Corp. taps his experience as a molecular biologist, preclinical investigator and sellside analyst. In this, the last of his three interviews …. Back in … Read more on Equities.com